Evolutionary Genomics, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Expirations
Evolutionary Genomics, Inc. reported Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Expirations of 110.88 thousand shares for the 12-month period ending 2020-12-31, per its 10-K filed 2021-03-31.
Discontinued › Notes › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations · last filed 2021-03-31
- Evolutionary Genomics, Inc. share-based compensation arrangement by share-based payment award, non-option equity instruments, expirations for the quarter ending 2020-12-31 was 110.86K shares.
- Evolutionary Genomics, Inc. share-based compensation arrangement by share-based payment award, non-option equity instruments, expirations for the quarter ending 2020-09-30 was 0.00 shares.
- Evolutionary Genomics, Inc. share-based compensation arrangement by share-based payment award, non-option equity instruments, expirations for the quarter ending 2020-06-30 was 0.00 shares.
- Evolutionary Genomics, Inc. share-based compensation arrangement by share-based payment award, non-option equity instruments, expirations for the quarter ending 2020-03-31 was 28.00 shares.
- Evolutionary Genomics, Inc. share-based compensation arrangement by share-based payment award, non-option equity instruments, expirations for fiscal 2020 was 110.88K shares.
- Evolutionary Genomics, Inc. share-based compensation arrangement by share-based payment award, non-option equity instruments, expirations for fiscal 2017 was 2.60K shares.
- Evolutionary Genomics, Inc. share-based compensation arrangement by share-based payment award, non-option equity instruments, expirations for fiscal 2015 was 13.64K shares, a 25.28% increase from fiscal 2014.
- Evolutionary Genomics, Inc. share-based compensation arrangement by share-based payment award, non-option equity instruments, expirations for fiscal 2014 was 10.88K shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Expirations 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Expirations 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Expirations 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Expirations 12 month |
|---|---|---|---|---|
| 2020-12-31 | 110.86K shares derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-31 | 110.86K shares derived: sum of 2 quarters · filed 2021-03-31 | 110.86K shares derived: sum of 3 quarters · filed 2021-03-31 | 110.88K shares 10-K · filed 2021-03-31 |
| 2020-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-13 | 0.00 shares derived: sum of 2 quarters · filed 2020-11-13 | 28.00 shares 10-Q · filed 2020-11-13 | |
| 2020-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-19 | 28.00 shares 10-Q · filed 2020-08-19 | ||
| 2020-03-31 | 28.00 shares 10-Q · filed 2020-05-12 | |||
| 2017-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2019-04-01 | 0.00 shares derived: sum of 2 quarters · filed 2019-04-01 | 0.00 shares derived: sum of 3 quarters · filed 2019-04-01 | 2.60K shares 10-K · filed 2019-04-01 |
| 2017-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-13 | 0.00 shares derived: sum of 2 quarters · filed 2017-11-13 | 2.60K shares 10-Q · filed 2017-11-13 | |
| 2017-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-03 | 2.60K shares 10-Q · filed 2017-08-03 | ||
| 2017-03-31 | 2.60K shares 10-Q · filed 2017-05-11 | |||
| 2015-12-31 | 13.64K shares 10-K · filed 2017-02-10 | |||
| 2014-12-31 | 10.88K shares 10-K · filed 2016-02-19 |